Tagged with Americas

Puerto Rico Isla Frio provides state-of-the-art temperature-controlled storage solutions for pharma, among other industries. Founder Geoffrey Parrillo discusses the company’s efforts to adapt to the demands of the pharma industry, offering solutions such as FDA-approved validated rooms. He also outlines Isla Frio’s unique real-time tracking technology, weighs in on the steps Puerto Rico…

Global Since Paul Hudson took the helm in 2019, Sanofi has been in transformation mode, shedding its consumer health assets to focus on high-growth areas like oncology, immunology, and vaccines. With bold investments in R&D and AI-driven innovation, the French pharma is positioning itself as a pure-play biopharma leader. In conversation…

Puerto Rico Puerto Rico leads all US jurisdictions in biopharmaceutical exports, shipping to over 120 countries. With a rapidly expanding life sciences sector and growing pharma logistics capabilities, the island is positioning itself as a global hub—but industry leaders say there’s still work to be done.   Life Sciences and Logistics Dynamo…

LatAm A roundup of top stories from Latin American pharma and healthcare, including the beginning of the Mexican government’s consolidated procurement of medicines; Libbs’ new biologics plant; Novo Nordisk’s USD 142.4 million investment in Brazil, and SteinCares’ plasma derivatives deal with Biotest.   Record dengue outbreak in Americas kills 7,700 this…

Puerto Rico CytoImmune, founded in 2017 and established in Puerto Rico in 2020, is focused on developing immune-based therapies using proprietary natural killer (NK) cells. CEO Dr José Eduardo Vidal discusses the biotech’s innovative approach, the access promise of allogeneic NK cells as opposed to T-cell therapies, the advantages of setting up…

Mexico Some 16 percent of Mexico’s population is battling diabetes—a number that represents one in five of the nation’s populace without including the vast numbers of undiagnosed Mexicans living with the disease. The new Mexican government has committed to reducing the burden of diabetes by stepping up primary care and preventive…

Puerto Rico Long recognized for its strengths in manufacturing and distribution, Puerto Rico is looking to capitalize on its positive attributes and position itself as a centre for innovation. While important tax incentives have provided stimulus for R&D, the US territory is also working on building a strong local ecosystem, developing and…

USA For those concerned that opinion and not science may determine US public health policy under president-elect Trump, the choice of surgeon Martin Makary as head of the FDA may be reassuring. While Makary is known as a healthcare critic, his views appear to be far less extreme than the controversial…

Puerto Rico As president of Puerto Rico’s Colegio de Químicos (CQPR), Dr. José A. Pérez Meléndez is focused on elevating the US territory’s standards of chemistry education and creating a bridge between industry and academia. He remarks on the Colegio’s strategic partnerships and talent retention efforts aimed at solidifying Puerto Rico’s standing…

Mexico Patricia Nakagawa, Managing Director of Karl Storz, Mexico Caribbean and Central America, explains the German family-owned MedTech’s ongoing evolution towards a more corporate structure and the new hub status she has helped to usher in for the regional affiliate. Nakagawa also highlights the company’s integrated operating room (OR) solution, as…

Mexico With the naming of Armida Zuñiga as head of the country’s regulatory body COFEPRIS, new Mexican president Claudia Sheinbaum has concluded the new government’s healthcare appointments and begun advancing her agenda by tackling Mexico’s widespread medicine shortages.   New Regulatory Lead By the time Claudia Sheinbaum was sworn in as…

Puerto Rico The Puerto Rico Consortium for Clinical Investigation (PRCCI) is a non-profit organisation offering specialised clinical trials services. Executive director Dr Amarilys Silva-Boschetti shares key developments since she last spoke with PharmaBoardroom in 2020, including the creation of a new clinical research centre with trials set to begin in 2024 and…